Greenland Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Greenland Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,000	Closed	-$596K	–	315
2026 Q1	$596K	Buy	+15,000	New	+$384K	0.08%	180

Greenland Capital Management's CNTA Position: Q2 2026 in Review

Greenland Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 15,000 shares — an estimated $596K sold.

Greenland Capital Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $596K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Greenland Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Greenland Capital Management sold 15,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $596K.
Greenland Capital Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Greenland Capital Management's Centessa Pharmaceuticals position peaked at $596K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Greenland Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.